Interactions of β-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral β-lactams

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 5, 1998, Pages 1168-1175

  Babini, Gioia S ^a,b   Yuan, Meifang ^a   Livermore, David M ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFIXIME; CEFPODOXIME; IMIPENEM; SANFETRINEM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CITROBACTER FREUNDII; DRUG HYDROLYSIS; ENTEROBACTER CLOACAE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PURIFICATION; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEUS VULGARIS; SERRATIA MARCESCENS; STEADY STATE;

EID: 0031960353     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.5.1168     Document Type: Article

References (36)

1. Afzal-Shah, M., F. Danel, G. S. Babini, and D. M. Livermore. Unpublished data.
2. Akova, M., G. Bonfiglio, and D. M. Livermore. 1991. Susceptibility to β-lactam antibiotics of Xanthomonas maltophilia mutants with high-and low-level constitutive expression of L-1 and L-2 β-lactamases. J. Med. Microbiol. 35:208-213.
3. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification of β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
4. Cartwright, S. J., and S. G. Waley. 1984. Purification of β-lactamases by affinity chromatography on phenylboronic acid-agarose. Biochem. J. 221: 505-512.
5. Charrel, R. N., J. M. Pages, P. De Micco, and M. Mallea. 1996. Prevalence of outer membrane protein alteration in β-lactam antibiotic-resistant Enterobacter aerogenes. Antimicrob. Agents Chemother. 40:2854-2858.
6. Chen, H. Y., and D. M. Livermore. 1993. Comparative activity of cefepime against chromosomal β-lactamase inducibility mutants of gram-negative bacteria. J. Antimicrob. Chemother. 32(Suppl. B):63-74.
7. Chen, H. Y., and D. M. Livermore. 1994. Comparative in-vitro activity of biapenem against enterobacteria with β-lactamase-mediated antibiotic resistance. J. Antimicrob. Chemother. 33:453-464.
8. Chow, J. V., M. J. Fine, D. M. Shales, J. P. Quinn, D. C. Hooper, M. P. Johnson, R. Ramphal, M. M. Wagener, D. K. Miyashiro, and V. L. Yu. 1991. Enterobacter hacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 115:585-590.
9. de Meester, F., B. Joris, G. Reckinger, C. Bellefroid-Bourguignon, J. M. Frere, and S. G. Waley. 1987. Automated analysis of enzyme inactivation phenomena. Application to β-lactamases and DD-peptidases. Biochem. Pharmacol. 36:2393-2403.
10. Felici, A., M. Perilli, B. Segatore, N. Franceschini, D. Setacci, A. Oratore, S. Stefani, M. Galleni, and G. Amicosante. 1995. Interactions of biapenem with active-site serine and metallo-β-lactamases. Antimicrob. Agents Chemother. 39:1300-1305.
11. Hancock, R. E., and A. M. Carey. 1979. Outer membrane of Pseudomonas aeruginosa: heat-and 2-mercaptoethanol-modifiable proteins. J. Bacteriol. 140:902-910.
12. Hancock, R. E. W., and F. Bellido. 1992. Factors involved in the enhanced efficacy against gram-negative bacteria of fourth-generation cephalosporins. J Antimicrob. Chemother. 29(Suppl. A):1-6.
13. Kiener, P. A., V. Knott-Hunziker, S. Petursson, and S. G. Waley. 1980. Mechanism of substrate-induced inactivation of β-lactamase I. Eur. J. Biochem. 109:575-580.
14. Ledent, P., X. Raquet, B. Joris, J. Van Beeumen, and J. M. Frere. 1993. A comparative study of class-D β-lactamases. Biochem. J. 292:555-562.
15. Livermore, D. M. 1987. Clinical significance of β-lactamase induction and stable derepression in gram-negative rods. Eur. J. Clin. Microbiol. 6:439-445.
16. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
17. Livermore, D. M. 1997. Acquired carbapenemases. J. Antimicrob. Chemother. 39:673-676.
18. 2 and pH on inhibition of TEM-1 and other β-lactamases by penicillanic acid sulfones. Antimicrob. Agents Chemother. 36:1870-1876.
19. Livermore, D. M., and J. D. Williams. 1996. β-Lactams: mode of action and mechanism of bacterial resistance, p. 502-577. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
20. Livermore, D. M., and M. Yuan. 1996. Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe. J. Antimicrob. Chemother. 38:409-424.
21. Lowry, O. H., N. J. Roseborough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
22. Lugtenberg, B., J. Meijers, R. Peters, P. van der Hoek, and L. van Alphen. 1975. Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands. FEBS Letts. 58:254-258.
23. Nordmann, P., S. Mariotte, T. Naas, R. Labia, and M.-H. Nicolas. 1993. Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother. 37:939-946.
24. Osano, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato. 1994. Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78.
25. Page, M. G. P. 1993. The kinetics of non-stoichiometric bursts of β-lactam hydrolysis catalysed by class C β-lactamase. Biochem. J. 295:295-304.
26. Paton R., R. S. Miles, J. Hood, and S. G. B. Amyes. 1993. ARI-1: β-lactamase-mediated resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 2:81-88.
27. Perez, A. N., I. B. Bonet, E. H. Robledo, R. S. Abascal, and C. V. Plous. 1996. Metallo-β-lactamase in Acinetobacter calcoaceticus. Med. Sci. Res. 24:315-317.
28. Persaud, K. C., R. H. Pain, and R. Virden. 1986. Reversible deactivation of β-lactamase by quinacillin. Extent of the conformational change in the isolated transitory complex. Biochem. J. 237:723-730.
29. Rasmussen, B. A., and K. Bush. 1997. Carbapenem hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41:223-232.
30. Rasmussen, B. A., K. Bush, D. Keeney, Y. Yang, R. Hare, C. O'Gara, and A. A. Medeiros. 1996. Characterization of IMI-1 β-lactamase, a novel class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother. 40:2080-2086.
31. Schiappa, D. A., M. K. Hayden, M. G. Matushek, F. N. Hasheni, J. Sullivan, K. Y. Smith, D. Miyashiro, J. P. Quinn, R. A. Weinstein, and G. M. Trenholme. 1996. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli blood stream infection: a case-control and molecular epidemiologic investigation. J. Infect. Dis. 174:529-536.
32. Senda, K., Y. Arakawa, K. Nakashima, H. Ito, S. Ichiyama, K. Shimokata, N. Kato, and M. Ohta. 1996. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother. 40:349-353.
33. Urban, C., E. Go, M. Mariano, and J. J. Rahal. 1995. Interaction of sulbactam, clavulanic acid and tazobactam with penicillin-binding proteins of imipenem-resistant and -susceptible Acinetobacter baumannii. FEMS Microbiol. Lett. 125:193-198.
34. Yang, Y., and D. M. Livermore. 1988. Activity of temocillin and other penicillins against β-lactamase-inducible and -stably derepressed enterobacteria. J. Antimicrob. Chemother. 22:299-306.
35. Yang, Y., and D. M. Livermore. 1988. Chromosomal β-lactamase expression and resistance to β-laclam antibiotics in Proteus vulgaris and Morganella morganii. Antimicrob. Agents Chemother. 32:1385-1391.
36. Yang, Y., D. M. Livermore, and R. J. Williams. 1988. Chromosomal β-lactamase expression and antibiotic resistance in Enterobacter cloacae. J. Med. Microbiol. 25:221-233.